首页> 外国专利> SERUM ANTIOXIDANTS AS PREDICTORS OF ADULT RESPIRATORY DISTRESS SYNDROME

SERUM ANTIOXIDANTS AS PREDICTORS OF ADULT RESPIRATORY DISTRESS SYNDROME

机译:血清抗氧化剂可预测成人呼吸窘迫综合征

摘要

At the initial diagnosis of sepsis (6-24h before the development of ARDS), serum manganese superoxide dismutase (MnSOD) levelsand catalase activities are increased in septic patients who subsequently developed ARDS compared to septic patients who did not developARDS. Increases in MnSOD and catalase may be used to predict the occurrence of ARDS in septic patients with the same sensitivity,specificity and efficiency as parallel assessments of serum lactate dehydrogenase (LDH) and Factor VIII levels. Evaluation of serum MnSODand catalase as well as these other accessible markers facilitates identification of subsets of patients and allow prospective treatment ofseptic patients who are destined to develop ARDS.
机译:在败血症的初步诊断(ARDS发生前6-24小时)时,血清锰超氧化物歧化酶(MnSOD)水平与未发展为脓毒症的脓毒症患者相比,随后发展为ARDS的脓毒症患者的血红素和过氧化氢酶活性增加ARDS。 MnSOD和过氧化氢酶的增加可用于预测具有相同敏感性的败血症患者中ARDS的发生,特异性和效率作为血清乳酸脱氢酶(LDH)和VIII因子水平的平行评估。血清MnSOD评估过氧化氢酶和过氧化氢酶以及其他可访问的标记物有助于识别患者的子集并允许对注定要发展ARDS的败血病患者。

著录项

  • 公开/公告号CA2158579C

    专利类型

  • 公开/公告日1999-01-26

    原文格式PDF

  • 申请/专利权人

    申请/专利号CA19942158579

  • 发明设计人 REPINE JOHN E.;LEFF JONATHAN A.;

    申请日1994-03-18

  • 分类号C12Q1/26;C12Q1/30;G01N33/573;

  • 国家 CA

  • 入库时间 2022-08-22 02:24:05

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号